{"id":"skp-0141","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5816058","moleculeType":null,"molecularWeight":"353.40"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"SKP-0141 functions as a procoagulant agent that promotes blood clotting through albumin-mediated delivery of clotting factors or direct enhancement of the coagulation cascade. The albumin fusion approach is intended to improve pharmacokinetics and reduce immunogenicity while maintaining hemostatic efficacy in bleeding disorders.","oneSentence":"SKP-0141 is a recombinant human albumin fusion protein designed to enhance hemostasis and reduce bleeding in patients with coagulation disorders.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:53:07.858Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemophilia or other inherited bleeding disorders"}]},"trialDetails":[{"nctId":"NCT06738901","phase":"PHASE3","title":"An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients","status":"NOT_YET_RECRUITING","sponsor":"SK Plasma Co., Ltd.","startDate":"2025-03-31","conditions":"Hemophilia A, Severe","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"SKP-0141","genericName":"SKP-0141","companyName":"SK Plasma Co., Ltd.","companyId":"sk-plasma-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"SKP-0141 is a recombinant human albumin fusion protein designed to enhance hemostasis and reduce bleeding in patients with coagulation disorders. Used for Hemophilia or other inherited bleeding disorders.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}